129 related articles for article (PubMed ID: 1829958)
1. Ondansetron; further progress in the prevention of nausea and vomiting induced by anti-cancer chemotherapy.
Sagar SM; Bayliss MA; Chong SL; Retsas S
Clin Oncol (R Coll Radiol); 1991 May; 3(3):183. PubMed ID: 1829958
[No Abstract] [Full Text] [Related]
2. Efficacy of ondansetron against nausea and vomiting caused by dacarbazine-containing chemotherapy.
Legha SS; Hodges C; Ring S
Cancer; 1992 Oct; 70(7):2018-20. PubMed ID: 1388090
[TBL] [Abstract][Full Text] [Related]
3. Ondansetron (GR38032F) plus dexamethasone: effective anti-emetic prophylaxis for patients receiving cytotoxic chemotherapy.
Smith DB; Newlands ES; Spruyt OW; Begent RH; Rustin GJ; Mellor B; Bagshawe KD
Br J Cancer; 1990 Feb; 61(2):323-4. PubMed ID: 2138031
[No Abstract] [Full Text] [Related]
4. Making chemotherapy easier.
Grunberg SM
N Engl J Med; 1990 Mar; 322(12):846-8. PubMed ID: 2137903
[No Abstract] [Full Text] [Related]
5. Antagonism of serotonin S3 receptors with ondansetron prevents nausea and emesis induced by cyclophosphamide-containing chemotherapy regimens.
Cubeddu LX; Hoffman IS; Fuenmayor NT; Finn AL
J Clin Oncol; 1990 Oct; 8(10):1721-7. PubMed ID: 2145400
[TBL] [Abstract][Full Text] [Related]
6. Prevention of delayed chemotherapy-induced nausea and vomiting after moderately high to highly emetogenic chemotherapy: comparison of ondansetron, prochlorperazine, and dexamethasone.
Lindley C; Goodin S; McCune J; Kane M; Amamoo MA; Shord S; Pham T; Yowell S; Laliberte K; Schell M; Bernard S; Socinski MA
Am J Clin Oncol; 2005 Jun; 28(3):270-6. PubMed ID: 15923800
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of ondansetron (GR 38032F) and the role of serotonin in cisplatin-induced nausea and vomiting.
Cubeddu LX; Hoffmann IS; Fuenmayor NT; Finn AL
N Engl J Med; 1990 Mar; 322(12):810-6. PubMed ID: 1689807
[TBL] [Abstract][Full Text] [Related]
8. Prevention of postoperative nausea and vomiting using ondansetron, a new, selective, 5-HT3 receptor antagonist.
Leeser J; Lip H
Anesth Analg; 1991 Jun; 72(6):751-5. PubMed ID: 1827966
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of serotonin-receptor antagonist antiemetic therapy over successive courses of carboplatin-based chemotherapy.
Markman MR; Peterson G; Kulp B; Markman M
Gynecol Oncol; 2002 Jun; 85(3):435-7. PubMed ID: 12051870
[TBL] [Abstract][Full Text] [Related]
10. Ondansetron.
Lancet; 1991 Sep; 338(8769):753-4. PubMed ID: 1679880
[No Abstract] [Full Text] [Related]
11. Oral treatment with ondansetron in an outpatient setting.
Dicato MA
Eur J Cancer; 1991; 27 Suppl 1():S18-9; discussion S22. PubMed ID: 1831630
[TBL] [Abstract][Full Text] [Related]
12. [Novel pharmacologic form of ondansetron (Zofran)--lingual tablets in the prevention of cytostatic chemotherapy-induced loss of appetite, nausea and vomiting].
Gershanovich ML; Beresneva IA; Makhnova EV
Vopr Onkol; 2003; 49(4):505-9. PubMed ID: 14569947
[TBL] [Abstract][Full Text] [Related]
13. Reduction of carboplatin induced emesis by ondansetron.
Harvey VJ; Evans BD; Mitchell PL; Mak D; Neave LM; Langley GB; Dickson DS
Br J Cancer; 1991 Jun; 63(6):942-4. PubMed ID: 1829954
[TBL] [Abstract][Full Text] [Related]
14. Ondansetron reduces chemotherapy induced nausea and vomiting refractory to standard antiemetics.
Mitchell PL; Evans BD; Allan SG; Forgeson GV; Mak D; Neave L; Humm G; Langley G; Dickson D; Harvey VJ
N Z Med J; 1992 Mar; 105(929):73-5. PubMed ID: 1532054
[TBL] [Abstract][Full Text] [Related]
15. A randomized double-blind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil, and doxorubicin or epirubicin chemotherapy.
Bonneterre J; Chevallier B; Metz R; Fargeot P; Pujade-Lauraine E; Spielmann M; Tubiana-Hulin M; Paes D; Bons J
J Clin Oncol; 1990 Jun; 8(6):1063-9. PubMed ID: 2140854
[TBL] [Abstract][Full Text] [Related]
16. Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy.
Smith DB; Newlands ES; Rustin GJ; Begent RH; Howells N; McQuade B; Bagshawe KD
Lancet; 1991 Aug; 338(8765):487-90. PubMed ID: 1714532
[TBL] [Abstract][Full Text] [Related]
17. Oral ondansetron (GR38032F) for the control of acute and delayed cyclophosphamide-induced emesis.
Rosso R; Campora E; Cetto G; Fosser V; Marangolo M; Oliva C
Anticancer Res; 1991; 11(2):937-9. PubMed ID: 1829602
[TBL] [Abstract][Full Text] [Related]
18. Anti-emetic control with ondansetron in the chemotherapy of breast cancer: a review.
Marschner N
Eur J Cancer; 1991; 27 Suppl 1():S15-7; discussion S22. PubMed ID: 1831629
[TBL] [Abstract][Full Text] [Related]
19. Low dose ondansetron and dexamethasone: a cost effective alternative to high dose metoclopramide/dexamethasone/lorazepam in the prevention of acute cisplatin induced emesis.
Sands R; Roberts JT; Marsh M; Gill A
Clin Oncol (R Coll Radiol); 1992 Jan; 4(1):67. PubMed ID: 1531293
[No Abstract] [Full Text] [Related]
20. Ondansetron in the prophylaxis of nausea and vomiting induced by carboplatin combination chemotherapy.
Gridelli C; Incoronato P; Airoma G; Pepe R; Arpinelli F; Bianco AR
Eur J Cancer; 1993; 29A(4):651. PubMed ID: 8435225
[No Abstract] [Full Text] [Related]
[Next] [New Search]
